Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combined oral phytotherapeutic regimen (also known as the Botanical Systemic Repigmentation Formula or the Horus/Tzenova regimen) is a natural, plant-based oral combination therapy developed by Green Fields Overseas for the treatment of vitiligo. The regimen consists of two distinct bioactive formulations administered together: Horus Formula4 (an antioxidant and amino acid-rich eye care capsule designed to support cellular recovery and provide building blocks for melanocyte survival) and Tzenova (a metabolic and immune-modulating supplement designed to regulate autoimmune responses and reduce melanocyte destruction). Together, they work synergistically to address the immune dysregulation, oxidative stress, and melanocyte loss characteristic of vitiligo, promoting progressive skin repigmentation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on combined oral phytotherapeutic regimen.